Home > Clinical Research
Clinical Research


The Clinical Research Department of Regional Urology sets us apart from many urology practices. We participate in numerous clinical research projects with the major pharmaceutical companies both across the country and internationally. This research helps bring new medication to the market for use in the future. We also have been able to offer new forms of therapy to our patients that are not available.

When our patients participate in the clinical trials at Regional Urology, it gives them the opportunity to have medications and procedures that are unavailable to the general public. Patients receive test and study medications at no cost. Participation is always voluntary.

The research department at Regional Urology, LLC perform studies in the following areas:

  • Overactive Bladder Symptoms
  • Stress Incontinence
  • Urge Incontinence
  • BPH
  • Erectile Dysfunction
  • Low Testosterone
  • Prostate Cancer
  • Bladder Cancer
  • Prostatitis
  • Interstitial Cystitis/Bladder Pain

Study for Patients with Secondary Hyperoxaluria with Kidney Stones

The purpose of this study is to learn more about the effect of an investigational drug called ALLN-177. It is designed to break down oxalate when taken with food. Oxlate is an organic chemical that occurs naturally in many foods. Leafy plants such as spinach and rhubarb contain large amounts of oxalate. Oxalate is removed from the body by the kidneys and passed into the urine. Some people have too much oxalate in the urine, and this can cause kidney stones and other health problems.

If ALLN-177 is successful in breaking down oxalate in foods in the gut and decreasing the amount of oxalate absorbed, it may help treat these medical conditions. The study will enroll male and female patients 18 years or older who have a history of hyperoxaluria. The study will be conducted at approximately 12 to 18 research centers in the United States.

Overactive Bladder and Urinary Incontinence Study

The purpose of this study is to look into the safety and effectiveness of Botox and Hydrogel admixture instilled into the bladder for the study treatment of Overactive Bladder with urinary incontinence.,

https://APOLLO-study.com/

Early Stage Prostate Cancer Study

The purpose of this study is to learn more about a prostate cancer treatment called sipuleucel-T, a cell-based immunotherapy, in early state prostate cancer that has not spread outside of the prostate. Sipuleucal-T has been approved by the U.S. Food and Drug Administration for the treatment of metastatic castrate resistant prostate cancer.

 

Premature Ejaculation Study

This study is being done for research purposes to test the effect of PSD502 (the study drug) compared to placebo for patients with premature ejaculation.


* Required





CONTACT US

Request to be contacted for an appointment

Click Here